Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Last Updated on: 24 February, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Procter & Gamble Health Ltd

About the Company - Procter & Gamble Health Ltd

Procter & Gamble Health Ltd. is a Public Limited Listed company incorporated on 26/04/1967 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1967PLC013726 and registration number is 013726. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 1114.41 Cr. and Equity Capital is Rs. 16.60 Cr. for the Year ended 30/06/2022.
PharmaceuticalsGodrej One, 8th Floor, Mumbai Maharashtra
NamePosition Held
Mr. Suresh TalwarChairman & Ind.Director
Mr. Milind ThatteManaging Director
Mr. Amit GuptaExecutive Director & CFO
Mr. Aalok AgrawalNon Executive Director
Dr. Elizabeth DesmondNon Executive Director
Mrs. Rani JadhavIndependent Director
Mr. S MadhavanIndependent Director
Mr. Lokesh ChandakDirector
Mr. Seema SambasivanDirector

Procter & Gamble Health Ltd. Share Price Update

Share PriceValue
Previous Day₹5,526.60

Basic Stock Data of Procter & Gamble Health Ltd

Market Cap 8,456 Cr.
Current Price 5,094
High / Low5,643/4,488
Stock P/E37.3
Book Value 485
Dividend Yield1.84 %
ROCE45.5 %
ROE33.5 %
Face Value 10.0

Data Source:

Competitors of Procter & Gamble Health Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Beta Drugs Ltd 1,259 Cr. 1,3101,595/60036.2 1480.00 %33.9 %28.6 % 10.0
Wanbury Ltd 523 Cr. 160166/33.021.9 6.800.00 %16.9 %% 10.0
Nectar Lifescience Ltd 906 Cr. 40.445.7/14.4112 47.60.00 %0.18 %6.01 % 1.00
Vivimed Labs Ltd 41.0 Cr. 4.958.16/4.85 21.30.00 %51.5 %163 % 2.00
Zota Health Care Ltd 1,384 Cr. 535535/270 39.50.19 %2.32 %7.42 % 10.0
Industry Average294.4 Cr148.2734.0252.640.04%20.96%41.01%6.6

Procter & Gamble Health Ltd Quarterly Results

MonthSep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Operating Profit788931487862695991109804589
OPM %30%37%14%17%29%22%26%20%31%35%25%15%29%
Other Income7632352335556
Profit before tax778626447460655587105794488
Tax %23%21%40%22%25%25%21%25%26%27%25%32%26%
Net Profit59681634554551416477593066
EPS in Rs35.7040.899.5020.4233.3627.0130.8224.8138.3546.2735.6617.9639.50

Procter & Gamble Health Ltd Quarterly Chart

Procter & Gamble Health Ltd Profit & Loss

MonthDec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Jun 2020Jun 2021Jun 2022Jun 2023TTM
Operating Profit10677598511677148204319246268325323
OPM %15%10%7%9%12%11%17%22%24%24%24%26%26%
Other Income202120222474768486618131821
Profit before tax117886783115132895234355233253314316
Tax %33%37%35%36%31%29%6%32%28%24%24%27%
Net Profit785643547994839159254177193229231
EPS in Rs47.2333.6626.0432.2747.6756.57505.2795.64153.07106.51115.98138.24139.39
Dividend Payout %5%25%23%23%23%27%87%0%150%122%45%44%

Procter & Gamble Health Ltd Profit & Loss Yearly Chart

Procter & Gamble Health Ltd Growth

Compounded Sales Growth
10 Years:6%
5 Years:12%
3 Years:-3%
Compounded Profit Growth
10 Years:11%
5 Years:23%
3 Years:-4%
Stock Price CAGR
10 Years:24%
5 Years:12%
3 Years:-10%
1 Year:11%
Return on Equity
10 Years:27%
5 Years:37%
3 Years:28%
Last Year:33%

Procter & Gamble Health Ltd Balance Sheet

MonthDec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Jun 2020Jun 2021Jun 2022Jun 2023
Equity Capital171717171717171717171717
Other Liabilities111125154192215258219250269275269338
Total Liabilities5946487087848799911,7591,0671,1769868881,101
Fixed Assets7585110132111115104101101104112144
Other Assets4945305476037117971,6399541,053843736925
Total Assets5946487087848799911,7591,0671,1769868881,101

Procter & Gamble Health Ltd Reserves and Borrowings Chart

Procter & Gamble Health Ltd Cash Flow

MonthDec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Jun 2020Jun 2021Jun 2022Jun 2023
Cash from Operating Activity 54058310754-130235247170236
Cash from Investing Activity -82711-68-75-481,270165-32-26-22
Cash from Financing Activity 0-5-17-12-15-22-30-883-387-289-98
Net Cash Flow-283-1417-161,109-483-172-145116

Procter & Gamble Health Ltd Financial Efficiency Indicators

MonthDec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Jun 2020Jun 2021Jun 2022Jun 2023
Debtor Days343844493964283026222734
Inventory Days160153162140145243154139113138124136
Days Payable4837405567128124106105209185239
Cash Conversion Cycle146154166134118179586334-49-34-69
Working Capital Days77707469529442222391816
ROCE %26%18%12%15%18%16%78%29%29%38%45%

Procter & Gamble Health Ltd Financial Efficiency Indicators Chart

Procter & Gamble Health Ltd Share Holding Pattern

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
No. of Shareholders50,32153,07658,81863,52565,53766,28965,72965,14863,83161,03058,85657,919

Procter & Gamble Health Ltd Shareholding Pattern Chart

No. of Procter & Gamble Health Ltd Shareholders

Procter & Gamble Health Ltd Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)
Nippon India Small Cap Fund5968070.75306.1
HDFC Small Cap Fund - Regular Plan3268340.66167.63
DSP Healthcare Fund1587044.2381.4
UTI MNC Fund1458872.8374.82
Sundaram Small Cap Fund745541.3338.24
UTI Healthcare Fund350002.117.95
Tata Retirement Savings Fund - Moderate Plan - Regular Plan310000.8615.9
Tata Retirement Savings Fund - Progressive Plan - Regular Plan288000.9114.77
Tata India Pharma & HealthCare Fund160001.098.21
Aditya Birla Sun Life MNC Fund - Div136710.27.01

Procter & Gamble Health Ltd ROCE Trend

Procter & Gamble Health Ltd EPS Trend

Procter & Gamble Health Ltd Key Financial Ratios

MonthJun 23Jun 22Jun 21Jun 20Dec 19
Basic EPS (Rs.)138.23116.00107.00153.0095.64
Diluted EPS (Rs.)138.23116.00107.00153.0095.64
Cash EPS (Rs.)154.72132.29124.60170.80105.98
Book Value[Excl.RevalReserv]/Share (Rs.)452.34371.38423.92545.99492.09
Book Value[Incl.RevalReserv]/Share (Rs.)452.34371.38423.92545.99492.09
Dividend / Share (Rs.)95.0052.50130.00230.00230.00
Revenue From Operations / Share (Rs.)740.73671.33607.67816.78558.23
PBDIT / Share (Rs.)206.23169.20159.11231.51151.53
PBIT / Share (Rs.)189.74152.88141.01213.76141.19
PBT / Share (Rs.)189.28152.63140.53213.76141.19
Net Profit / Share (Rs.)138.23115.97106.51153.0695.64
PBDIT Margin (%)27.8425.2026.1828.3427.14
PBIT Margin (%)25.6122.7723.2026.1725.29
PBT Margin (%)25.5522.7323.1226.1725.29
Net Profit Margin (%)18.6617.2717.5218.7317.13
Return on Networth / Equity (%)30.5531.2225.1228.0319.43
Return on Capital Employeed (%)39.5038.5731.3237.4127.76
Return On Assets (%)20.8321.5417.9221.6114.88
Asset Turnover Ratio (%)
Current Ratio (X)2.622.603.044.213.80
Quick Ratio (X)
Inventory Turnover Ratio (X)2.552.772.290.008.11
Dividend Payout Ratio (NP) (%)0.00147.43215.93287.450.00
Dividend Payout Ratio (CP) (%)0.00129.25184.57257.590.00
Earning Retention Ratio (%)0.00-47.43-115.93-187.450.00
Cash Earning Retention Ratio (%)0.00-29.25-84.57-157.590.00
Interest Coverage Ratio (X)444.60668.74330.150.000.00
Interest Coverage Ratio (Post Tax) (X)299.01459.38222.000.000.00
Enterprise Value (Cr.)8273.456626.398817.136112.466656.85
EV / Net Operating Revenue (X)6.735.958.744.517.18
EV / EBITDA (X)24.1723.5933.3815.9126.47
MarketCap / Net Operating Revenue (X)
Retention Ratios (%)0.00-47.43-115.93-187.450.00
Price / BV (X)11.6011.2813.207.458.84
Price / Net Operating Revenue (X)

Procter & Gamble Health Ltd Profitability Ratios (%)

Procter & Gamble Health Ltd Liquidity Ratios

Procter & Gamble Health Ltd Liquidity Ratios (%)

Procter & Gamble Health Ltd Interest Coverage Ratios (X)

Procter & Gamble Health Ltd Valuation Ratios

Fair Value / Intrinsic Value of Procter & Gamble Health Ltd

Fair Value: ₹6171.83

The stock is undervalued by 21.16% compared to the current price ₹5094

*Investments are subject to market risks

Strength and Weakness of Procter & Gamble Health Ltd

  1. The stock has a high average ROCE of 27.00%, which is a positive sign.
  2. The company has higher reserves (723.75 cr) compared to borrowings (1.92 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (520.31 cr) and profit (246.31 cr) over the years.
  1. The stock is trading at a high valuation with an average P/B ratio of 183.52 and average Dividend Yield of 24.61%.
  2. The stock has a high average Working Capital Days of 47.17, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 75.00, which may not be favorable.

Should I Buy Procter & Gamble Health Ltd Share Now?

  • Considering various financial indicators, investors might exercise caution regarding investment in Procter & Gamble Health Ltd:
    1. Net Profit Margin: 18.66%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 39.50% (Industry Average ROCE: 27.12%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. Interest Coverage Ratio (Post Tax): 299.01
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    4. Quick Ratio: 2.18
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    5. ✓ Stock P/E: 37.3 (Industry average Stock P/E: 53.72)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    6. ✗ Total Debt / Equity: N/A
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis suggests exercising caution. It's advisable to conduct further research or consult with financial experts before considering any investment.

About the Author

Author Avatar

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Procter & Gamble Health Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE